Humana Reports First Quarter 2021 Financial Results; Reaffirms Full Year 2021 Adjusted EPS Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Humana (HUM) PT Raised to $505 at Cantor Fitzgerald Following Earnings
April 28, 2021 11:13 AM EDTCantor Fitzgerald analyst Steven Halper raised the price target on Humana (NYSE: HUM) to $505.00 (from $450.00) while maintaining an Overweight rating.
The analyst commented, "We reiterate our Overweight rating on HUM shares and increase our price target to $505 from $450. This morning, April 28, the company... More
Humana (HUM) Tops Q1 EPS by 60c, Maintains FY EPS Guidance
April 28, 2021 6:33 AM EDTHumana (NYSE: HUM) reported Q1 EPS of $7.67, $0.60 better than the analyst estimate of $7.07. Revenue for the quarter came in at $20.67 billion versus the consensus estimate of $20.52 billion.
GUIDANCE:
Humana sees FY2021 EPS of $21.25-$21.75, versus the consensus of $21.54.
For earnings history and earnings-related data on Humana (HUM) click here.
... More


